Ansell Benjamin J, Watson Karol E, Fogelman Alan M, Navab Mohamad, Fonarow Gregg C
Atherosclerosis Research Unit, Division of Cardiology, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
J Am Coll Cardiol. 2005 Nov 15;46(10):1792-8. doi: 10.1016/j.jacc.2005.06.080. Epub 2005 Oct 19.
Although high-density lipoproteins (HDL) possess many features that contribute to the association between elevated HDL cholesterol and protection from atherosclerosis, these lipoproteins may be modified in certain individuals and/or circumstances to become proinflammatory. The ability of HDL to inhibit or paradoxically to enhance vascular inflammation, lipid oxidation, plaque growth, and thrombosis reflects changes in specific enzyme and protein components. The anti-inflammatory and proinflammatory functional properties of HDL can now be assessed using cell-based and cell-free assays. Acute or chronic systemic inflammation and the metabolic syndrome appear to render HDL proinflammatory. In contrast, statins and experimental agents such as apolipoprotein A-1 mimetics render HDL more anti-inflammatory. Functional characterization of HDL is a promising method for enhanced assessment of cardiovascular risk and effectiveness of risk reduction.
尽管高密度脂蛋白(HDL)具有许多特性,这些特性促成了HDL胆固醇升高与预防动脉粥样硬化之间的关联,但在某些个体和/或情况下,这些脂蛋白可能会发生改变而变得具有促炎作用。HDL抑制或反常地增强血管炎症、脂质氧化、斑块生长和血栓形成的能力反映了特定酶和蛋白质成分的变化。现在可以使用基于细胞和无细胞的检测方法来评估HDL的抗炎和促炎功能特性。急性或慢性全身炎症以及代谢综合征似乎会使HDL具有促炎作用。相比之下,他汀类药物和诸如载脂蛋白A-1模拟物等实验性药物会使HDL更具抗炎性。HDL的功能特性表征是一种增强心血管风险评估和降低风险有效性评估的有前景的方法。